BCVS Scientific Sessions 2020

Basic Cardiovascular Science Scientific Sessions
Emerging Opportunities in Cardiovascular Diseases

July 27–30, 2020
Now a Virtual Event
Registration Information
Want to watch #BCVS20 but didn't sign up in time? Purchase access below.

If you already attended #BCVS20, you can re-watch for 90 days without purchasing additional access.
Virtual Livestream

Log in to PHD first for a faster experience. Need to find your account or password?

Our 2020 virtual meeting was a great success! Now, all registered attendees have access to watch any virtual session at any time for 90 days (until October 30th, 2020.)

Watch when you want!

Did you miss a concurrent session that you really wanted to see? Are you interested in the 25 hours of CME/CE accreditation available? Want to watch a session again? No problem!

If you already registered for BCVS 2020, just enter the sessions by clicking the button at the top of the page that reads, "Already Registered? Watch OnDemand Sessions." (We recommend bookmarking this link.) To access BCVS ePosters, recorded moderated poster sessions, exhibits and more, visit our Heart Hub. The content on the Heart Hub will stay open-access.

What if I didn't register during or before BCVS 2020?

If you didn't attend BCVS 2020 while it was happening but would like to see the sessions now, click the "purchase access" button in the Registration box above to buy OnDemand™. The cost is $99 for AHA Members, and $199 for Non-members. You'll be able to access the sessions for up to two years (July 2022.) BCVS OnDemand contains nearly 30 hours of meeting content, 80 presentations and 25 hours of CME/CE.

Program & Agenda

Visit the BCVS 2020 Heart Hub for:

  • Up-to-the-minute conference schedule
  • Early Career and breakout Zoom sessions
  • Exhibitors
  • CME/CE information
AHA Basic Cardiovascular Sciences | Visit the BCVS Heart Hub - The heart of your virtual event experience. Access >

About this Meeting

The 15th annual BCVS 2020 Scientific Sessions has become the premier conference for molecular cardiovascular biology and disease. Sponsored by the American Heart Association Basic Cardiovascular Sciences Council, the world’s leading organization of cardiovascular scientists, the conference attracts leading researchers in fields such as microRNAs, cardiac gene and cell therapy, cardiac development and most recently tissue engineering and iPS cells.

The planned agenda includes 15 fast-paced sessions during 3½ days, set in a forum that promotes the relaxed exchange and discussion of cutting edge research in molecular and translational cardiovascular biology and disease. The program includes a diversity of speakers representing the best cardiovascular scientists from around the world.

In addition, the symposium will be of great value to scientists and executives of pharmaceutical companies and biotechnology firms who are in the cardiovascular space.

Target Audience

  • Basic cardiovascular scientists
  • Molecular/cellular biologists
  • Physiologists
  • Translational investigators
  • Clinical trialists
  • Practicing cardiologists
  • Cardiovascular nurses and pharmacists

Learning Objectives

At the conclusion of the conference, participants will be able to:
  1. Discuss the latest research on cardiac metabolism and their implications for clinical practice.
  2. Identify critical areas of research and research gaps in heart failure.
  3. Describe current knowledge gaps in research and understanding of the cardiopulmonary effects of e-cigarette use.
  4. Describe opportunities to bring a greater emphasis on translational research to your work.
  1. Discuss the cardiovascular effects of traditional, targeted, and immunological therapies for cancer patients and on their role in the management and prevention of these conditions.
  2. Describe the potential role of and challenges involved in the use of big data analytics to precision medicine to guide cardiovascular research and patient care, and their implications for your work.